Syndax Pharmaceuticals Inc

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC SNDX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

142,407

Value ($000)

2,992

Weight

0.0%

2020 Q4 - 2025 Q4 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	2,992	0.0%	142,407	12/31/2025
2025 Q3	11/14/2025	2,066	0.0%	134,261	9/30/2025
2025 Q2	8/14/2025	2,399	0.0%	256,138	6/30/2025
2025 Q1	5/19/2025	2,466	0.0%	200,696	3/31/2025
2024 Q4	2/14/2025	2,249	0.0%	170,100	12/31/2024
2024 Q3	11/14/2024	2,646	0.0%	137,447	9/30/2024
2024 Q2	8/14/2024	3,148	0.0%	153,360	6/30/2024
2024 Q1	5/15/2024	2,305	0.0%	96,833	3/31/2024
2023 Q4	2/14/2024	2,011	0.0%	93,067	12/31/2023
2023 Q3	11/13/2023	1,113	0.0%	76,663	9/30/2023
2023 Q2	8/11/2023	1,134	0.0%	53,682	6/30/2023
2023 Q1	5/15/2023	1,134	0.0%	53,682	3/31/2023
2022 Q4	2/14/2023	1,479	0.0%	58,095	12/31/2022
2022 Q3	11/14/2022	1,041	0.0%	43,303	9/30/2022
2022 Q2	8/12/2022	890	0.0%	46,257	6/30/2022
2022 Q1	5/16/2022	676	0.0%	38,872	3/31/2022
2021 Q4	2/14/2022	851	0.0%	38,872	12/31/2021
2021 Q3	11/15/2021	743	0.0%	38,872	9/30/2021
2021 Q2	8/16/2021	733	0.0%	42,672	6/30/2021
2021 Q1	5/14/2021	858	0.0%	38,387	3/31/2021
2020 Q4	3/1/2021	583	0.0%	26,200	12/31/2020